FDAnews
www.fdanews.com/articles/114157-fda-accepts-medarex-filing-to-develop-new-cancer-drug

FDA Accepts Medarex Filing to Develop New Cancer Drug

January 29, 2009
Medarex Inc., a biopharmaceutical company … announced that the Food & Drug Administration has accepted its application for an investigational new drug to treat renal cell carcinoma and non-Hodgkin’s lymphoma.
NJBIZ